Literature DB >> 10561804

Effects of chelation with EDTA and vitamin B therapy on nitric oxide-related endothelial vasodilator function.

D J Green1, J G O'Driscoll, A Maiorana, N B Scrimgeour, R Weerasooriya, R R Taylor.   

Abstract

1. 'Chelation therapy' with EDTA is being frequently used in patients with cardiovascular disease, despite limited objective evidence of effectiveness. Depressed nitric oxide (.NO)-related endothelial function accompanies atherosclerosis, and even the vascular risk factors alone, and is improved by numerous interventions that also improve prognosis in vascular disease. 2. The aim of the present study was to determine the influence of chelation therapy with EDTA alone and EDTA in combination with B vitamins on endothelial function. 3. After a control series of saline infusions, we examined the effects of a series of EDTA infusions (1.5 g, 10 times over 6 weeks) in eight subjects with coronary artery disease. In addition, because EDTA is commonly supplemented by other components, particularly B group vitamins, we subsequently examined the effect of a similar series of vitamin-supplemented EDTA infusions. 4. Forearm blood flow (FBF) was assessed by plethysmography and graded intrabrachial infusions of the endothelium-dependent vasodilator acetylcholine (ACh) and the endothelium-independent dilator sodium nitroprusside (SNP). 5. There was no difference in vasodilation to either drug after EDTA alone compared with the control periods, but the response to ACh was augmented after combined therapy (P < 0.03, ANOVA). The latter was accompanied by a small but consistent mean (+/- SEM) fall in plasma homocysteine of 1.6 +/- 0.5 mumol/L (P < 0.05). 6. The selective increase in the vasodilator response to ACh after therapy with EDTA and several B group vitamins indicates that NO-related endothelial function was improved. The absence of response to EDTA alone suggests that the supplementary vitamins were necessary for this benefit, which may have been related to the accompanying decrease in plasma homocysteine. These results, along with the current interest in the possible cardioprotective effects of vitamins and the increasing administration of 'chelation therapy', call for more definitive studies on these aspects of 'alternative medicine'.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10561804     DOI: 10.1046/j.1440-1681.1999.03156.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  5 in total

1.  Design of the Trial to Assess Chelation Therapy (TACT).

Authors:  Gervasio A Lamas; Christine Goertz; Robin Boineau; Daniel B Mark; Theodore Rozema; Richard L Nahin; Jeanne A Drisko; Kerry L Lee
Journal:  Am Heart J       Date:  2012-01       Impact factor: 4.749

Review 2.  EDTA chelation therapy for cardiovascular disease: a systematic review.

Authors:  Dugald M R Seely; Ping Wu; Edward J Mills
Journal:  BMC Cardiovasc Disord       Date:  2005-11-01       Impact factor: 2.298

3.  Protective effect of EDTA preadministration on renal ischemia.

Authors:  Chiara Foglieni; Alessandro Fulgenzi; Paolo Ticozzi; Fabio Pellegatta; Clara Sciorati; Daniela Belloni; Elisabetta Ferrero; Maria Elena Ferrero
Journal:  BMC Nephrol       Date:  2006-03-15       Impact factor: 2.388

4.  Association between heavy metal levels and acute ischemic stroke.

Authors:  Ching-Huang Lin; Yi-Ting Hsu; Cheng-Chung Yen; Hsin-Hung Chen; Ching-Jiunn Tseng; Yuk-Keung Lo; Julie Y H Chan
Journal:  J Biomed Sci       Date:  2018-05-25       Impact factor: 8.410

Review 5.  Chelation Therapy in Patients With Cardiovascular Disease: A Systematic Review.

Authors:  Filippo Ravalli; Xavier Vela Parada; Francisco Ujueta; Rachel Pinotti; Kevin J Anstrom; Gervasio A Lamas; Ana Navas-Acien
Journal:  J Am Heart Assoc       Date:  2022-03-01       Impact factor: 6.106

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.